Evidence map›Paper›PMID 20595385›Full record

ArticleThe Journal of biological chemistry2010

The nicotinic acetylcholine receptor and the Na,K-ATPase alpha2 isoform interact to regulate membrane electrogenesis in skeletal muscle.

Judith A Heiny, Violetta V Kravtsova, Frederic Mandel, Tatiana L Radzyukevich, Boubacar Benziane, Alexander V Prokofiev, Steen E Pedersen, Alexander V Chibalin, Igor I Krivoi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
1.1field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 60 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. E-cigarette aerosol impairs male mouse skeletal muscle force development and prevents recovery from injury.American journal of physiology. Regulatory, integrative and comparative physiology · 2022
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The role of AMPK in regulation of NaJournal of muscle research and cell motility · 2021
    Review
  11. Article
  12. Skeletal Muscle Na,K-ATPase as a Target for Circulating Ouabain.International journal of molecular sciences · 2020
    Article
  13. Article
  14. Cholesterol and the Safety Factor for Neuromuscular Transmission.International journal of molecular sciences · 2019
    Review
  15. Article
  16. Review
  17. Isoform-specific role of Na/K-ATPase α1 in skeletal muscle.American journal of physiology. Endocrinology and metabolism · 2018
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Judith A HeinyDepartment of General Physiology, St. Petersburg State University, St. Petersburg 199034, Russia.
Violetta V Kravtsova
Frederic Mandel
Tatiana L Radzyukevich
Boubacar Benziane
Alexander V Prokofiev
Steen E Pedersen
Alexander V Chibalin
Igor I Krivoi
St Petersburg University · RUKarolinska Institutet · SEUniversity of Cincinnati · USBaylor College of Medicine · US

Funding

NHLBI NIH HHS HL6606
6 · The paper itself

Abstract

The nicotinic acetylcholine receptor (nAChR) and the Na,K-ATPase functionally interact in skeletal muscle (Krivoi, I. I., Drabkina, T. M., Kravtsova, V. V., Vasiliev, A. N., Eaton, M. J., Skatchkov, S. N., and Mandel, F. (2006) Pflugers Arch. 452, 756-765; Krivoi, I., Vasiliev, A., Kravtsova, V., Dobretsov, M., and Mandel, F. (2003) Ann. N.Y. Acad. Sci. 986, 639-641). In this interaction, the specific binding of nanomolar concentrations of nicotinic agonists to the nAChR stimulates electrogenic transport by the Na,K-ATPase alpha2 isozyme, causing membrane hyperpolarization. This study examines the molecular nature and membrane localization of this interaction. Stimulation of Na,K-ATPase activity by the nAChR does not require ion flow through open nAChRs. It can be induced by nAChR desensitization alone, in the absence of nicotinic agonist, and saturates when the nAChR is fully desensitized. It is enhanced by noncompetitive blockers of the nAChR (proadifen, QX-222), which promote non-conducting or desensitized states; and retarded by tetracaine, which stabilizes the resting nAChR conformation. The interaction operates at the neuromuscular junction as well as on extrajunctional sarcolemma. The Na,K-ATPase alpha2 isozyme is enriched at the postsynaptic neuromuscular junction and co-localizes with nAChRs. The nAChR and Na,K-ATPase alpha subunits specifically coimmunoprecipitate with each other, phospholemman, and caveolin-3. In a purified membrane preparation from Torpedo californica enriched in nAChRs and the Na,K-ATPase, a ouabain-induced conformational change of the Na,K-ATPase enhances a conformational transition of the nAChR to a desensitized state. These results suggest a mechanism by which the nAChR in a desensitized state with high apparent affinity for agonist interacts with the Na,K-ATPase to stimulate active transport. The interaction utilizes a membrane-delimited complex involving protein-protein interactions, either directly or through additional protein partners. This interaction is expected to enhance neuromuscular transmission and muscle excitation.

Indexed as

AnimalsCaveolin 3Dose-Response Relationship, DrugEnzyme InhibitorsLidocaineMaleMembrane PotentialsMembrane ProteinsNeuromuscular JunctionNicotinic AgonistsNicotinic AntagonistsPhosphoproteinsProadifenProtein BindingRatsRats, WistarAtp1a2 protein, ratCav3 protein, ratCaveolin 3Enzyme InhibitorsLidocaineMembrane ProteinsNicotinic AgonistsNicotinic AntagonistsphospholemmanPhosphoproteinsProadifenQX-222Receptors, NicotinicSodium-Potassium-Exchanging ATPase

Identifiers

PMID20595385
PMCPMC2937887
OpenAlexW1972675596

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.